Literature DB >> 8852660

Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease.

J Amiel1, T Attié, D Jan, A Pelet, P Edery, C Bidaud, D Lacombe, P Tam, J Simeoni, E Flori, C Nihoul-Fékété, A Munnich, S Lyonnet.   

Abstract

Hirschsprung disease (HSCR, aganglionic megacolon) is a frequent congenital malformation regarded as a multigenic neurocristopathy. Two susceptibility genes have been recently identified in HSCR, namely the RET proto-oncogene and the endothelin B receptor (EDNRB) gene. Hitherto however, homozygosity for EDNRB mutations accounted for the HSCR-Waardenburg syndrome (WS) association. Here, we report heterozygous EDNRB missense mutations (G57S, R319W and P383L) in isolated HSCR. These data might suggest that EDNRB mutations could be dosage sensitive: heterozygosity would predispose to isolated HSCR with incomplete penetrance, while homozygosity would result in more complex neurocristopathies associating HSCR and WS features. In addition, the present data give further support to the role of the endothelin-signalling pathway in the development of neural crest-derived enteric neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852660     DOI: 10.1093/hmg/5.3.355

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

1.  RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease.

Authors:  S Borrego; A Ruiz; M E Saez; O Gimm; X Gao; M López-Alonso; A Hernández; F A Wright; G Antiñolo; C Eng
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

Review 2.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

3.  A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.

Authors:  Salud Borrego; Fred A Wright; Raquel M Fernández; Nita Williams; Manuel López-Alonso; Ramana Davuluri; Guillermo Antiñolo; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

Review 4.  Waardenburg syndrome.

Authors:  A P Read; V E Newton
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

5.  Genetic background impacts developmental potential of enteric neural crest-derived progenitors in the Sox10Dom model of Hirschsprung disease.

Authors:  Lauren C Walters; V Ashley Cantrell; Kevin P Weller; Jack T Mosher; E Michelle Southard-Smith
Journal:  Hum Mol Genet       Date:  2010-08-25       Impact factor: 6.150

Review 6.  Enteric nervous system and developmental abnormalities in childhood.

Authors:  Thambipillai Sri Paran; Udo Rolle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2006-12       Impact factor: 1.827

7.  Mutation of RET proto-oncogene in Hirschsprung's disease and intestinal neuronal dysplasia.

Authors:  Jin-Fa Tou; Min-Ju Li; Tao Guan; Ji-Cheng Li; Xiong-Kai Zhu; Zhi-Gang Feng
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

8.  Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis.

Authors:  Akira Hachiya; Akemi Kobayashi; Yasuko Yoshida; Takashi Kitahara; Yoshinori Takema; Genji Imokawa
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Abnormalities of the enteric nervous system in heterozygous endothelin B receptor deficient (spotting lethal) rats resembling intestinal neuronal dysplasia.

Authors:  G B T von Boyen; H-J Krammer; A Süss; C Dembowski; H Ehrenreich; T Wedel
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

10.  Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb.

Authors:  Andrew S McCallion; Erine Stames; Ronald A Conlon; Aravinda Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.